Christian Dr Sander - Pharma

Author Information

Christian Sander is a distinguished researcher affiliated with the Department of Computational Biology at the Memorial Sloan-Kettering Cancer Center in New York, NY, USA. His work mainly focuses on the intersection of computational biology and pharmacogenomics, contributing significantly to the understanding of cancer treatment and protein structure prediction.

Research Contributions

In 2021 alone, Christian Sander has made substantial contributions to the field, with multiple research papers addressing various aspects of computational biology. His work spans from capturing scientific knowledge in a computable form to exploring the molecular response to PARP1 inhibition in ovarian cancer cells. Significant contributions include the development of PredictProtein, a tool predicting protein structure and function for nearly three decades, and the creation of CellMinerCDB, a database exploring patient-derived cancer cell line pharmacogenomics. His research is instrumental in advancing our understanding of cancer treatment adaptation, protein design using generative models, and the similarity of cell line tumors across different cancers.

Aliases

Christian Sander is also known by several aliases including Chris Sander, C. Sander, and C Sander. These variations may appear in different publications and databases but refer to the same individual.

Publication and Citation Metrics

Metric	Value
Citation Count	189,519
h-index	152
Paper Count	480

Publications:

Capturing scientific knowledge in computable form

DOI: 10.1101/2021.03.10.382333

Year: 2021

Targeting Adaptation to Cancer Treatment by Drug Combinations

DOI: 10.1101/2021.04.14.439861

Year: 2021

Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics

DOI: 10.1186/s13048-021-00886-x

Year: 2021

Protein design and variant prediction using autoregressive generative models

DOI: 10.1038/s41467-021-22732-w

Year: 2021

PredictProtein - Predicting Protein Structure and Function for 29 Years

DOI: 10.1093/nar/gkab354

Year: 2021

A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles

DOI: 10.1016/j.crmeth.2021.100039

Year: 2021

PredictProtein – Predicting Protein Structure and Function for 29 Years

DOI: 10.1101/2021.02.23.432527

Year: 2021

CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics

DOI: 10.1093/nar/gkaa968

Year: 2021

AlignmentViewer: Sequence Analysis of Large Protein Families [version 1; peer review: 1 approved, 1 approved with reservations]

DOI:

Year: 2021

The reactome pathway knowledgebase 2022

DOI: 10.1093/nar/gkab1028

Year: 2021

What is Medication Adherence?

What Causes Adverse Drug Events?

What Types of Medications are Used?

What are the Benefits of Collaborative Care Models?

What Are the Challenges in Managing Chronic Conditions?

What is the Future of ADE Management?

What is Generic Competition?

What are the Implications for Pharma Companies?

What Role Does Cellular Stress Play in Disease?

How Do Pharmacists Contribute to Patient Care?

Partnered Content Networks

Relevant Topics